Skip to content
Trial Eligibility
Menu

Alzheimer's Disease Clinical Trials near Tampa, FL

20 studies for Alzheimer's Disease are recruiting at 35 sites within 50 miles of Tampa, Florida, according to ClinicalTrials.gov data processed .

Distances are city-level approximations. See all Alzheimer's Disease trials in the US or all trials near Tampa.

Your ZIP is looked up in your browser. We don't receive or store it.

Recruiting now

Alzheimer's Disease studies enrolling near Tampa

Showing 20 studies, nearest first.
  1. Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)

    NCT05980949

    • Phase 3
    • Ages 55 to 90 years
    • Sex: All

    Nearest sites: Angels Clinical Research Institute Tampa - Palm Springs - PPDS (Tampa, FL); Guardian Angel Research (Tampa, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  2. A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease

    NCT06540833

    • Phase 2
    • Ages 55 years and older
    • Sex: All

    Nearest sites: University of South Florida (Tampa, FL); Clinical Research of Brandon (Brandon, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  3. A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia

    NCT06651567

    • Phase 2
    • Ages 55 years and older
    • Sex: All

    Nearest sites: Psych Me Medical Research Inc (Tampa, FL); Quantum Research Associates Corp (Tampa, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  4. A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)

    NCT07033494

    • Phase 2
    • Ages 50 to 85 years
    • Sex: All

    Nearest sites: Axiom Brain Health ( Site 1029) (Tampa, FL); K2 Medical Research ( Site 1020) (Tampa, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  5. A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).

    NCT07602582

    • Phase 3
    • Ages 55 years and older
    • Sex: All

    Nearest sites: Care Access - Tampa (Tampa, FL); Suncoast Clinical Research, Inc. (New Port Richey, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  6. Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia

    NCT06584357

    • Observational
    • Ages 60 to 90 years
    • Sex: All
    • Accepts healthy volunteers

    Nearest sites: Axiom Brain Health (Tampa, FL); Intercoastal Medical Group, Inc. (Sarasota, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  7. A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

    NCT06585787

    • Phase 3
    • Ages 55 to 90 years
    • Sex: All

    Nearest sites: Guardian Angel Research (Tampa, FL); Interventional Psychiatry of Tampa Bay (Tampa, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  8. Palliative Care Education in Assisted Living for Dementia Care Providers (PCEAL-DCP)

    NCT06722352

    • Interventional
    • Ages 21 years and older
    • Sex: All
    • Accepts healthy volunteers

    Nearest sites: University of South Florida (Tampa, FL); University of South Florida (Tampa, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  9. A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)

    NCT06976203

    • Phase 3
    • Ages 60 to 85 years
    • Sex: All

    Nearest sites: USF Health Byrd Alzheimer's Institute (Tampa, FL); Intercoastal Medical Group (Sarasota, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  10. A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease

    NCT07011745

    • Phase 3
    • Ages 55 to 90 years
    • Sex: All

    Nearest sites: IPTB Clinical Research (Tampa, FL); Key Clinical Research (Bradenton, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  11. ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's Disease

    NCT03671889

    • Interventional
    • Ages 50 to 85 years
    • Sex: All

    Nearest site: Tampa General Hospital (Tampa, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  12. A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)

    NCT05511363

    • Phase 3
    • Ages 55 to 90 years
    • Sex: All

    Nearest site: University of South Florida (Tampa, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  13. Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease

    NCT06808984

    • Phase 2
    • Ages 55 to 90 years
    • Sex: All

    Nearest site: University of South Florida, Department of Psychiatry and Behavioral Neurosciences (Tampa, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  14. A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis

    NCT06887192

    • Phase 2
    • Ages 55 to 90 years
    • Sex: All

    Nearest site: Clinical Site (Tampa, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  15. A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)

    NCT06937229

    • Phase 3
    • Ages 55 to 90 years
    • Sex: All

    Nearest site: IPTB Clinical Research (Tampa, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  16. AV-1980R (Tau Vaccine) in Preclinical Alzheimer's Disease (TAURUS-1980)

    NCT07158905

    • Phase 1
    • Ages 65 to 80 years
    • Sex: All

    Nearest site: University of South Florida (Tampa, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  17. Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

    NCT07177352

    • Phase 3
    • Ages 50 to 90 years
    • Sex: All

    Nearest site: Axiom Brain Health LLC (Tampa, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  18. A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)

    NCT07589595

    • Phase 2
    • Ages 55 to 85 years
    • Sex: All

    Nearest site: Axiom Brain Health LLC (Tampa, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  19. Microbiome in Aging of Gut and Brain

    NCT07799402

    • Observational
    • Ages 18 years and older
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: Department of Neurosurgery and Brain and Spine and Faculty of USF Center for Microbiome Re-search, Microbiomes Institute (Tampa, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  20. A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease

    NCT07599670

    • Phase 1/2
    • Ages 50 to 90 years
    • Sex: All

    Nearest site: Key Clinical Research LLC /ID# 277800 (Bradenton, FL)

    Distance to nearest recruiting site
    ~32 mi (city-level)
    Recruiting sites
    1 site within 50 mi

FAQ

Common questions

What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining an Alzheimer's Disease clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.